levoketoconazole 150 MG Oral Tablet [Recorlev]
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
levoketoconazole 150 MG Oral Tablet [Recorlev]
150 MG · Oral Tablet · oral
A form of levoketoconazole →
levoketoconazole 150 MG Oral Tablet [Recorlev] — Imidazole and triazole derivatives. Strength, form, class, interactions & more.
![levoketoconazole 150 MG Oral Tablet [Recorlev]](https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=d4c5fead-bc4a-fb02-e053-2a95a90ae4fc&name=bottle-label.jpg)
Active ingredient
Classification
Imidazole and triazole derivativesCortisol Synthesis Inhibitor
Drug interactions
Levoketoconazole has several significant drug interactions that may affect the efficacy and safety of concomitant medications.
- majorCYP3A4 substrates — Increases plasma concentrations of the substrate and may increase the risk of the substrate’s adverse reactions.
- majorAtorvastatin — Increases plasma concentration of atorvastatin and may increase the risk of atorvastatin-associated myopathy and rhabdomyolysis.
- majorMetformin — Increases plasma concentration of metformin and may increase the risk of metformin’s adverse reactions.
- majorStrong CYP3A4 inhibitors — May increase plasma concentrations of levoketoconazole and increase the risk of adverse reactions from RECORLEV.
- majorStrong CYP3A4 inducers — May decrease plasma concentrations of levoketoconazole and reduce the efficacy of RECORLEV.
- majorGastric acid neutralizers — Impairs absorption of levoketoconazole from RECORLEV.
Real-world adverse events (FAERS)
Fatigue209Nausea180Headache149Vomiting93Dizziness82Diarrhoea76Pain71Arthralgia65
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication